Dr Gaurav Agrawal

MBBS, MRCP, FRACGP,

Gastroenterology Fellow and General Practitioner

Graduated from St George’s Hospital Medical School, London in 2006

Has obtained MRCP (UK), FRACGP and aiming to obtain the FACP and FRACP by the end of the year

After a year’s internship in the UK, Dr Agrawal relocated to Australia after reading about Prof Borody’s research in scientific journals at medical school. There was a desire for the chance to learn and work with Professor Borody, especially in the field of Crohn’s disease and the use of Anti-MAP, which fitted with his hypothesis during his learning.

Dr Agrawal completed his junior years in Australia and then became a qualified General Practitioner with the Royal Australasian College of GPs. Subsequently, he re-embarked upon hospital training on the way to completing his aim to become a Gastroenterologist by 2018. He has worked at numerous hospitals along the NSW coast for his training.

In addition, he is a member of the UK Royal College of Physicians and an International Member of the American College of Physicians and Gastroenterologists.

He is a leading expert in Crohn’s disease and the use of Anti-MAP treatment. In addition, other interests are the gut microbiome, parasitic infections, faecal transplants and H.Pylori. He will be researching the diagnostic testing of Mycobacterium paratuberculosis as well as the investigation into a novel therapeutic vaccine for the condition.

Publications

PUBLICATIONS:

– Aitken J, Agrawal G, Markova N et al. Demonstration of Intracellular Mycobacterium Species in Crohn’s Disease Using Novel Technologies. American College of Gastroenterology Annual Scientific Meeting and Postgraduate Course Poster. 16 – 21 October 2015 Honolulu, Hawaii.

– Agrawal G, Borody TJ, Turner R et al. Combining infliximab, anti-MAP and hyperbaric oxygen therapy for resistant fistulizing Crohn’s disease. Future Sci. OA (2015) FSO1577

Agrawal G, Borody TJ, Chamberlin W. ‘Global Warming’ to Mycobacterium avium ss paratuberculosis’. Future Microbiology July 2014, 9 (7)
Borody T, Agrawal G, et al. ‘Rescue H.pylori therapy in the Clinical Setting’. Poster at the American College of Gastroenterology meeting Oct 2012.
Jaworski A, Borody TJ, Ramrakha S, Sharma R, Leis S, Agrawal G, Gadalla S. Antibiotic Therapy for Treatment-Naïve Crohn’s Disease Patients. Program No. P370. ACG 2016 Annual Scientific Meeting Abstracts.Las Vegas, NV: American College of Gastroenterology.
Borody T J, Paramsothy S, Agrawal G. ‘Fecal Microbiota Transplantation: Indications, Methods, Evidence, and Future Directions’. Curr Gastroenterol Rep (Jul 2013) 15: 337.
Borody T J, Brandt L, Paramsothy S, Agrawal G. ‘Fecal microbiota transplantation: a new standard treatment option for Clostridium difficile infection’. Expert Rev. Anti. Infect. Ter. 11(5), (2013)